MaxCyte

MXCT

----

Current ValuationThe current P/E ratio is -4.23, within the reasonable range, cheaper than 40.41% of the time in the past 3 years, and the industry ranks 35/58, the industry Median -2.41.

-4.23xP/E

Stock price$1.46Earnings per share$-0.35

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x20x40x60x80x100x

P/E ratio
Name/Symbol
LZAGYUSLonza	-401.84x	--	$55.32B
CRLUSCharles River Laboratorie	-70.44x	238.50%	$16.80B
TEMUSTempus AI	-73.74x	17.12%	$13.96B
RGENUSRepligen	-856.20x	138.66%	$10.11B
BRKRUSBruker	-80.53x	7.71%	$8.61B
TXGUS10X Genomics	-113.23x	108.91%	$8.51B
ADPTUSAdaptive Biotechnologies	-64.48x	38.37%	$4.12B
ABCLUSAbcellera Biologics	-23.97x	36.29%	$3.95B
ALMRUSAlamar Biosciences	-42.23x	80.56%	$2.10B
FTREUSFortrea	-29.00x	95.76%	$1.99B
MRVIUSMaravai LifeSciences	-25.00x	64.44%	$1.93B
PSNLUSPersonalis	-15.69x	18.96%	$1.68B
AZTAUSAzenta	-13.24x	176.92%	$1.63B
CYRXUSCryoport	-18.36x	156.25%	$833.18M
CTKBUSCytek Biosciences	-9.61x	33.98%	$774.70M
PACBUSPacific Biosc California	-5.77x	75.55%	$758.43M
OABIUSOmniAb	-17.22x	39.35%	$748.76M
DNAUSGinkgo Bioworks	-2.49x	35.20%	$724.58M
EVOUSEvotec SE	-2.41x	383.30%	$550.57M
TKNOUSAlpha Teknova	-27.01x	7.81%	$452.90M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.